RETINALGENIX TECHNOLOGIES

retinalgenix-technologies-logo

RetinalGenix Technologies develops a medical device to prevent blindness due to diabetic retinopathy and maculopathy. RetinalGenix's mission is the prevention of blindness through mass retinal screening and patient home monitoring throughout the world.

#SimilarOrganizations #People #Website #More

RETINALGENIX TECHNOLOGIES

Industry:
Health Care Medical Device Wellness

Founded:
2017-01-01

Address:
Petaluma, California, United States

Country:
United States

Website Url:
http://www.retinalgenix.com

Status:
Active

Contact:
(415) 578-9583

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Universal Analytics Joomla! RokNavMenu IntenseDebate


Similar Organizations

intralink-spine-logo

Intralink-Spine

Intralink-Spine manufactures and commercializes an injectable medical device to treat spinal disc degeneration and low back pain.

waypoint-orthopedics-logo

Waypoint Orthopedics

Waypoint Orthopedics makes vertebral fixation safer and more efficient for patients, surgeons, and support staff.

Current Employees Featured

erhan-gunday_image

Erhan Gunday
Erhan Gunday Co-Founder and CTO @ RetinalGenix Technologies
Co-Founder and CTO

Official Site Inspections

http://www.retinalgenix.com

  • Host name: 30.97.215.35.bc.googleusercontent.com
  • IP address: 35.215.97.30
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "RetinalGenix Technologies"

About & Mission - RetinalGeniX

The World Health Organization said that the increasing toll of Non-Communicable Diseases meant that if the trend were to continue, by around 2050, chronic diseases such as …See details»

RetinalGeniX

Welcome to RetinalGeniX Our mission is the prevention of blindness and the early detection and treatment of multiple systemic and ocular diseases. Pharmaco-Genetic Mapping ™ Proprietary …See details»

RetinalGenix Technologies Inc. (RTGN)

Dec 31, 2023 RetinalGenix Technologies Inc. is an innovative ophthalmic research and development company seeking to revolutionize early disease detection and improve patient …See details»

Company Info :: RetinalGenix Technologies Inc. (RTGN)

Company Contact. RetinalGenix Technologies Inc. 409 Apollo Beach Blvd Ste 6 Apollo Beach, FL 33572 Toll-Free: (800) 331-5446See details»

RetinalGenix Technologies - Crunchbase Company …

Organization. RetinalGenix Technologies . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ...See details»

RetinalGenix Technologies - Contacts, Employees, Board Members ...

Organization. RetinalGenix Technologies . Connect to CRM . Save . ... Employee Profiles 2. About. RetinalGenix Technologies has 2 current employee profiles, including Chairman, …See details»

RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness …

Sep 18, 2023 About RetinalGeniX™ RetinalGeniX is an ophthalmic research and development company focused on developing technologies for the early detection and treatment of ocular …See details»

RetinalGeniX Contracts With Avania CRO to Provide Guidance for ...

RetinalGeniX Technologies Inc. Jerry Katzman, MD, CEO [email protected] +1 (415) 578-9761 www.retinalgenix.com. About Avania Avania is a leading, global, full-service contract …See details»

RetinalGenix - VentureRadar

Pearl Technology AG develops medical devices for Computed Tomography and Magnetic Resonance Imaging that allows a higher patient throughput, increased image quality and …See details»

RetinalGenix Technologies Inc Com (RTGN) reports earnings - Quartz

2 days ago RetinalGenix Technologies Inc Com (RTGN 0.00%) has submitted its 10-K filing for the fiscal year ended December 31, 2024. Suggested Reading Does CoreWeave's …See details»

RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.

Dec 21, 2023 PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) — RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the …See details»

RetinalGeniX Technologies focuses on prevention of blindness, …

Sep 19, 2023 RetinalGeniX Technologies Inc. released to the public via OCT Markets a video webinar regarding the retinal screening medical device technology being developed by the …See details»

RetinalGeniX Contracts With Avania CRO to Provide Guidance for ...

RetinalGeniX Technologies Inc. Jerry Katzman, MD, CEO [email protected] +1 (415) 578-9761 www.retinalgenix.com. About Avania Avania is a leading, global full-service contract …See details»

RetinalGenix Develops Remote Imaging Device - Retinal Physician

Feb 21, 2025 RetinalGenix plans to refine the prototype prior to manufacturing. When a final device prototype is completed, the company contemplates installing units in various settings, …See details»

RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D.

The company is making progress in conducting pharmaceutical clinical studies for treating dry Age-Related Macular Degeneration (AMD) through Avania, its contract research organization …See details»

RetinalGeniX Technologies Inc. Focuses on Prevention of Blindness …

PETALUMA, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) — RetinalGeniX Technologies Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”) released to the public via OTC Markets, a …See details»

Retinagenix Therapeutics - VentureRadar

"We are developing our lead product candidate, RGX-001 (Zuretinol Acetate), for the treatment of vision threatening diseases including Retinitis Pigmentosa, Leber Congenital Amaurosis and …See details»

RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.

PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of …See details»

RetinalGeniX™ Technologies Inc. Granted a Patent for System And …

Feb 22, 2024 A New Patent Granted for an Affordable and Effective Device and Method To Detect Ocular And Systemic Diseases. PETALUMA, Calif., Feb. 22, 2024 (GLOBE …See details»

Therapeutics – RetinalGeniX

Problem. 200 million people worldwide are estimated to have AMD as of 2022, and by 2024, this number is projected to be ~300 million 1.. There are no FDA-approved drugs to …See details»

linkstock.net © 2022. All rights reserved